Operating Lease, Right-of-Use Asset of PROVECTUS BIOPHARMACEUTICALS, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PROVECTUS BIOPHARMACEUTICALS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • PROVECTUS BIOPHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $138,451, a 277% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $138,451 +$101,750 +277% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $150,133 +$101,509 +209% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $12,392 -$48,006 -79% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $24,624 -$47,402 -66% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $36,701 -$46,808 -56% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $48,624 -$46,227 -49% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $60,398 -$45,656 -43% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $72,026 -$45,097 -39% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $83,509 -$44,550 -35% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $94,851 -$44,012 -32% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $106,054 +$90,877 +599% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $117,123 +$77,560 +196% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $128,059 +$69,323 +118% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $138,863 +$58,054 +72% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $15,177 -$85,638 -85% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $39,563 -$81,258 -67% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $58,736 -$80,474 -58% 30 Sep 2021 10-Q 10 Nov 2021 2021 FY
Q2 2021 $80,809 -$76,790 -49% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $100,815 -$75,624 -43% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $120,821 -$73,579 -38% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $139,210 -$72,977 -34% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $157,599 -$72,376 -31% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $176,439 -$71,324 -29% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $194,400 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 $212,187 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $229,975 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $247,763 31 Mar 2019 10-Q 13 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.